Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Environ Res ; 146: 173-84, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26765097

RESUMO

The exposome provides a framework for understanding elucidation of an uncharacterized molecular mechanism conferring enhanced susceptibility of macrophage membranes to bacterial infection after exposure to the environmental contaminant benzo(a)pyrene, [B(a)P]. The fundamental requirement in activation of macrophage effector functions is the binding of immunoglobulins to Fc receptors. FcγRIIa (CD32a), a member of the Fc family of immunoreceptors with low affinity for immunoglobulin G, has been reported to bind preferentially to IgG within lipid rafts. Previous research suggested that exposure to B(a)P suppressed macrophage effector functions but the molecular mechanisms remain elusive. The goal of this study was to elucidate the mechanism(s) of B(a)P-exposure induced suppression of macrophage function by examining the resultant effects of exposure-induced insult on CD32-lipid raft interactions in the regulation of IgG binding to CD32. The results demonstrate that exposure of macrophages to B(a)P alters lipid raft integrity by decreasing membrane cholesterol 25% while increasing CD32 into non-lipid raft fractions. This robust diminution in membrane cholesterol and 30% exclusion of CD32 from lipid rafts causes a significant reduction in CD32-mediated IgG binding to suppress essential macrophage effector functions. Such exposures across the lifespan would have the potential to induce immunosuppressive endophenotypes in vulnerable populations.


Assuntos
Poluentes Atmosféricos/toxicidade , Benzo(a)pireno/toxicidade , Macrófagos/efeitos dos fármacos , Microdomínios da Membrana/efeitos dos fármacos , Nistatina/farmacologia , beta-Ciclodextrinas/farmacologia , Células Cultivadas , Humanos , Imunoglobulina G/metabolismo , Macrófagos/imunologia , Receptores de IgG/genética , Receptores de IgG/metabolismo , Transdução de Sinais
2.
Toxicol Sci ; 149(1): 42-54, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26420751

RESUMO

To characterize behavioral deficits in pre-adolescent offspring exposed in utero to Benzo(a)pyrene [B(a)P], timed-pregnant Long Evans Hooded rats were treated with B(a)P (150, 300, 600, and 1200 µg/kg BW) or peanut oil (vehicle) on E14, 15, 16, and 17. Following birth, during the pre-weaning period, B(a)P metabolites were examined in plasma and whole brain or cerebral cortex from exposed and control offspring. Tissue concentrations of B(a)P metabolites were (1) dose-dependent and (2) followed a time-dependence for elimination with ∼60% reduction by PND5 in the 1200 µg/kg BW experimental group. Spatial discrimination-reversal learning was utilized to evaluate potential behavioral neurotoxicity in P40-P60 offspring. Late-adolescent offspring exposed in utero to 600 and 1200 µg/kg BW were indistinguishable from their control counterparts for ability to acquire an original discrimination (OD) and reach criterion. However, a dose-dependent effect of in utero B(a)P-exposure was evident upon a discrimination reversal as exposed offspring perseverated on the previously correct response. This newly characterized behavioral deficit phenotype for the first reversal was not apparent in either the (1) OD or (2) subsequent reversal sessions relative to the respective control offspring. Furthermore, the expression of activity related-cytoskeletal-associated protein (Arc), an experience-dependent cortical protein marker known to be up-regulated in response to acquisition of a novel behavior, was greater in B(a)P-exposed offspring included in the spatial discrimination cohort versus home cage controls. Collectively, these findings support the hypothesis that in utero exposure to B(a)P during critical windows of development representing peak periods of neurogenesis results in behavioral deficits in later life.


Assuntos
Benzo(a)pireno/toxicidade , Feto/efeitos dos fármacos , Deficiências da Aprendizagem/induzido quimicamente , Animais , Proteínas Reguladoras de Apoptose/genética , Comportamento Animal/efeitos dos fármacos , Benzo(a)pireno/farmacocinética , Disponibilidade Biológica , Feminino , Proteínas Musculares/genética , Fenótipo , Gravidez , Ratos , Ratos Long-Evans , Distribuição Tecidual
3.
Int J Biochem Mol Biol ; 6(1): 1-16, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26045972

RESUMO

Interleukin-34 (IL-34) is a cytokine consisting of a 39kD homodimer, shown to be a ligand for both the Macrophage Colony Stimulating Factor (M-CSF/CSF-1) receptor and the Receptor-like protein tyrosine phosphatase-zeta (RPTP-ƺ). IL-34 has been shown to promote monocyte viability and proliferation as well as the differentiation of bone marrow cells into macrophage progenitors. Published work on IL-34 involves its effects on normal hematopoietic and osteoclast progenitors. However, it is not known whether IL-34 has biologic effects in cancer, including leukemia. Here we report that the biological effects of IL-34 include induction of differential expression of Interleukins-1α and -1ß as well as induction of differentiation of U937, HL-60 and THP-1 leukemia cell lines demonstrating monocyte-like characteristics. The ability of IL-34 to induce monocytic-like differentiation is supported by strong morphological and functional evidence. Cell surface markers of myeloid lineage, CD64 and CD86, remain constant while the levels of CD11b and CD71 decline with IL-34 treatment. IL-34 also induced increases in CD14 and CD68 expression, further supporting maturation toward monocytic character. IL-34-induced differentiated U937 and THP-1 cell lines exhibited biological functions such as endocytosis and respiratory burst activities. Collectively, we conclude that while IL-34 does not induce cell growth or proliferation, it is able to induce differentiation of leukemia cell lines from monoblastic precursor cells towards monocyte- and macrophage-like cells, mediated through the JAK/STAT and PI3K/Akt pathways. To our knowledge, this is the first report that IL-34 induces differentiation in human leukemic cells, let alone any cancer model.

4.
J Health Econ Outcomes Res ; 3(1): 73-82, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-37662654

RESUMO

Objectives: To develop consensus statements outlining the impact of endoscopic linear stapling device stability on potential complications of thoracic surgery and the stress/concern of thoracic surgeons. Methods: Eight thoracic surgeons representing 8 countries participated in a Delphi panel process using 2 anonymous surveys. The first included binary, multiple-response, and Likert scale-type questions, which were converted into affirmative statements for survey 2 if an adequate number of respondents answered similarly. Consensus was defined a priori when ≥70% agreed with the affirmative statement in survey 2. Results: All panelists completed both surveys. Panelists unanimously agreed that: 1) an endoscopic linear stapling device with improved stability would result in less stress/concern for critical firings, surgeries where a fellow is trained, and robot-assisted surgeries requiring an assistant; 2) reduced unintentional tissue/structure damage and reduced tension on tissue being fired upon may result from use of an endoscopic linear stapling device that provides improvement in stability; and 3) endoscopic linear stapling device stability had more clinical importance in video-assisted thoracic surgery compared to open thoracic surgery. Conclusions: Improved endoscopic linear stapling device stability is a critical component of thoracic surgery likely to result in more frequent positive surgical outcomes when compared to a device with greater instability.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...